Project 1 Sample Clauses
Project 1. Subject to Section 6.5.3, 6.9, 6.10 and 6.12, with respect to Products containing GSK Development Compounds arising solely out of Project 1, GSK shall pay to Anacor [***] in the Territory at the royalty rates as set forth in the table below. The applicable royalty rates for a particular Product shall depending on whether GSK elected the GSK Development Compound contained in such Product by exercising a Candidate Selection Option or a PoC Option. [***]
Project 1. GSK shall make the non-refundable, non-creditable milestone payments to Anacor that are set forth below in either Section 6.3.1(a) or Section 6.3.1(b), as applicable, upon occurrence of the corresponding milestone event with respect to a Collaboration Compound resulting from Project 1. Such payments shall be subject to the additional terms and conditions set forth in Sections 6.3.1(c), 6.3.5, 6.8, 6.10 and 6.12.
Project 1. A. UNIVERSITY GMP manufacturing of a cell-based vaccine (BriaVax SV-BR-l-GM) and a control cell line scope of work and cost estimates given to COMPANY’S employee on May 14, 2015: Corporate Office – US Briacell Therapeutics Corp. 8▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Tel: 8▇▇-▇▇▇-▇▇▇▇ FAX: 4▇▇-▇▇▇-▇▇▇▇ D▇. ▇▇▇▇▇▇▇ ▇. Wiseman Chairman and CEO Briacell Therapeutics Corp. 8▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇. ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Mobile: 3▇▇-▇▇▇-▇▇▇▇ Email: c▇@▇▇▇▇▇▇▇▇.▇▇▇
B. Work associated with the Services: Transfer of technology and procedures from BriaCell to the UC Davis GMP Facility. Generation of GMP Standard Operating Procedures (SOPs). Manufacturing and cryopreservation of the vaccine cell line (400 vials with 15 million cells/vial). Manufacturing and cryopreservation of the control cell line (100 vials with 2 million cells/vial). Quality control and release tests on the cells, generation of appropriate documentation. Storage of the cryopreserved vaccine and control cell line vials for 1 year. Shipping of the vaccine and control cell line vials (4 shipments estimated).
Project 1. Was the project completed within past three years? 2. Purpose of project? 3. Was the system supplying water prior to repair or upgrade? 4. If this is a Guzzler fill in the blanks below. □ Yes □ New well □ Yes Apron Size: □ No* □ New Dirt Tank □ No* *If No skip the rest of section □ New Catchment Guzzler *Skip question if new water development. Storage Gallons: □ Repair or upgrade existing water system. *Must answer following question.
Project 1. GSK shall make the non-refundable, non-creditable milestone payments to Anacor that are set forth below in either Section 6.3.1(a) or Section 6.3.1(b), as applicable, upon occurrence of the corresponding milestone event with respect to a Collaboration Compound resulting from Project 1. Such payments shall be subject to the additional terms and conditions set forth in Sections 6.3.1(c), 6.3.5, 6.8, 6.10 and 6.12. [***] THE SYMBOL [***] IS USED TO INDICATE THAT A PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION.